BASELINE CHARACTERISTICS AND COMORBIDITIES |
BASELINE
CHARACTERISTICS AND COMORBIDITIES |
BASELINE CHARACTERISTICS AND
COMORBIDITIES |
BASELINE CHARACTERISTICS AND COMORBIDITIES |
BASELINE CHARACTERISTICS AND COMORBIDITIES |
Age (years) |
71 [15.5] |
66 [22] |
72 [10] |
0.22 |
Weight (Kg) |
76.5 [21.25] |
80 [29] |
75 [21] |
0.18 |
Height (cm) |
170 [15] |
170 [14] |
170 [17] |
0.83 |
BMI (kg/m2) |
27.0 [7.45] |
27.7 [7] |
25.4
[5.3] |
0.09 |
Smoking History (Y/N/Ex) |
8+14+4 |
3+3+3 |
5+11+1 |
All
ns |
Cardiomyopathy - HF |
4 (15%) |
0 |
4 (24%) |
0.26 |
Hypertension |
16 (62%) |
4 (44%) |
12 (71%) |
0.23 |
Pacemaker |
0 |
0 |
0 |
- |
Pulmonary disease - COPD |
6 (23%) |
1 (11%) |
5 (29%) |
0.38 |
Diabetes Mellitus |
1 (4%) |
0 |
1 (6%) |
1.00 |
Chronic Kidney Disease |
4 (15%) |
1 (11%) |
3 (18%) |
1.00 |
Beta-blockers |
7 (27%) |
2 (22%) |
5 (29%) |
1.00 |
ACE-Inhibitor - ARB |
7 (27%) |
1 (11%) |
6 (35%) |
0.36 |
VENTILATION DATA AT THE TIME OF ECHOCARDIOGRAPHY |
VENTILATION DATA AT THE TIME OF ECHOCARDIOGRAPHY |
VENTILATION DATA AT THE TIME OF ECHOCARDIOGRAPHY |
VENTILATION DATA AT THE TIME OF ECHOCARDIOGRAPHY |
VENTILATION DATA AT THE TIME OF ECHOCARDIOGRAPHY |
Ventilation mode
ETI (Pressure Control Mode)
NIV + HFNC
|
17 (65%)
7+2 (35%)
|
3 (33%)
5+1 (67%)
|
14 (82%)
2+1 (18%)
|
0.03
(ETI vs others)
|
FiO2 (%) |
70 [25] |
60 [29] |
75 [33] |
0.18 |
Respiratory Rate (bpm) |
18 [7.25] |
21 [7] |
18 [7] |
0.22 |
Tidal Volume (ml, if ETI) |
485 [55] |
490 |
480 [70] |
0.70 |
PEEP (cmH2O) |
10 [4] |
10 [4] |
10 [3] |
0.87 |
P/F Ratio |
105 [65.7] |
142 [77.5] |
99 [44.3] |
0.052 |
SaO2 (%) |
96 [4.25] |
97 [3] |
96 [5] |
0.31 |
ARTERIAL BLOOD GAS DATA AT THE TIME OF ECHOCARDIOGRAPHY |
ARTERIAL BLOOD GAS DATA AT THE TIME OF ECHOCARDIOGRAPHY |
ARTERIAL BLOOD GAS DATA AT THE TIME OF ECHOCARDIOGRAPHY |
ARTERIAL BLOOD GAS DATA AT THE TIME OF ECHOCARDIOGRAPHY |
ARTERIAL BLOOD GAS DATA AT THE TIME OF
ECHOCARDIOGRAPHY |
PaO2 (mmHg) |
78 [24.2] |
81 [27] |
71.50
[26] |
0.36 |
PaCO2 (mmHg) |
42 [15.5] |
42 [14] |
42 [26] |
0.63 |
pH |
7.41 [0.09] |
7.44 [0.11] |
7.40 [0.08] |
0.09 |
Base Deficit (mmol/L) |
1.40 [4.9] |
2.2 [6.0] |
0.6 [6.7] |
0.08 |
Lactate (mmol/L) |
1.8 [1.0] |
1.5 [0.7] |
1.8 [1.9] |
0.49 |
Time to CCE (days) |
1 [1.25] |
2 [3] |
1 [1] |
0.83 |
HEMODYNAMIC DATA AT THE TIME OF ECHOCARDIOGRAPHY |
HEMODYNAMIC DATA AT THE TIME OF ECHOCARDIOGRAPHY |
HEMODYNAMIC DATA AT THE TIME OF ECHOCARDIOGRAPHY |
HEMODYNAMIC DATA AT THE TIME OF ECHOCARDIOGRAPHY |
HEMODYNAMIC DATA AT THE TIME OF ECHOCARDIOGRAPHY |
Heart Rate (bpm) |
71 [25] |
71 [16] |
71 [39] |
0.96 |
Atrial fibrillation (n) |
4 (15%) |
0 |
4 (24%) |
0.26 |
Systolic Arterial Pressure (mmHg) |
119 [31.5] |
129 [38] |
118
[26] |
0.92 |
Diastolic Arterial Pressure (mmHg) |
64 [19] |
65 [19] |
64
[18] |
0.49 |
Mean Arterial Pressure (mmHg) |
84 [21.5] |
92 [23] |
84
[24] |
0.49 |
NE infusion (n)
Dose of NE (if used, ยต/kg/min)
|
6 (23%)
0.04
|
1 (11%)
-
|
5 (29%)
-
|
0.38
|
OUTCOME DATA |
OUTCOME DATA |
OUTCOME DATA |
OUTCOME DATA |
OUTCOME DATA |
ICU Length of Stay |
15 [9.75] |
18 [22] |
11 [9] |
0.01 |
ICU Mortality |
15 (58%) |
- |
- |
- |
Hospital Mortality |
17 (65%) |
- |
- |
- |